Biotricity (BTCY) Institutional Ownership → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free BTCY Stock Alerts $1.06 +0.01 (+0.95%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings Institutional Ownership Changes (13F Filings) for Biotricity (OTCMKTS:BTCY)CurrentInstitutional OwnershipPercentage3.89%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$382.50KNumber ofInstitutional Sellers(last 12 months)0 Get BTCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Biotricity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTCY Institutional Buying and Selling by Quarter Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Biotricity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/10/2023 AE Wealth Management LLC250,100$159K0.0%+66.6%2.858% 5/4/2023 Strengthening Families & Communities LLC289,575$135K0.0%N/A0.551% 4/14/2023 AE Wealth Management LLC150,100$70K0.0%+199.6%0.286% 7/27/2022 Bouchey Financial Group Ltd26,748$47K0.0%N/A0.052% 7/26/2022 Bouchey Financial Group Ltd26,748$47K0.0%N/A0.052% 7/22/2022 Signature Wealth Management Partners LLC34,173$60K0.1%+26.9%0.067% 7/14/2022 Cedar Mountain Advisors LLC15,000$27K0.0%N/A0.029% 4/29/2022 Caldwell Investment Management Ltd.110,550$265K0.2%N/A0.216% 2/10/2022B. Riley Wealth Management Inc.12,500$50K0.0%N/A0.025% 2/10/2022 HighTower Advisors LLC47,220$188K0.0%-17.0%0.096% 1/24/2022 Cedar Mountain Advisors LLC15,000$60K0.0%+200.0%0.031% 1/19/2022 Signature Wealth Management Partners LLC23,923$95K0.1%+99.4%0.049% 12/8/2021 Moors & Cabot Inc.10,000$29K0.0%N/A0.020% 12/6/2021 OLD Second National Bank of Aurora15,000$44K0.0%N/A0.031% 11/16/2021 National Asset Management Inc.10,925$33K0.0%N/A0.022% 11/15/2021 HighTower Advisors LLC56,900$167K0.0%N/A0.135% 11/12/2021 Magnus Financial Group LLC18,370$54K0.0%N/A0.044% 11/5/2021 Moors & Cabot Inc.33,324$344K0.0%N/A0.079% 10/20/2021 StoneX Group Inc.10,959$32K0.0%N/A0.026% 10/20/2021 Signature Wealth Management Partners LLC12,000$35K0.0%N/A0.028% (Data available from 1/1/2016 forward) BTCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTCY shares? During the previous two years, the following institutional investors and hedge funds held shares of Biotricity shares: AE Wealth Management LLC ($159K), Strengthening Families & Communities LLC ($135K), Signature Wealth Management Partners LLC ($60K), and Bouchey Financial Group Ltd ($47K), Cedar Mountain Advisors LLC ($27K).Learn more on BTCY's institutional investors. What percentage of Biotricity stock is owned by institutional investors? 3.89% of Biotricity stock is owned by institutional investors. Learn more on BTCY's institutional investor holdings. Which institutional investors have been buying Biotricity stock? The following institutional investors have purchased Biotricity stock in the last 24 months: Strengthening Families & Communities LLC ($289.58K), AE Wealth Management LLC ($200K), Bouchey Financial Group Ltd ($53.50K), Cedar Mountain Advisors LLC ($15K), and Signature Wealth Management Partners LLC ($7.25K). How much institutional buying is happening at Biotricity? Institutional investors have bought a total of 565,321 shares in the last 24 months. This purchase volume represents approximately $2.27M in transactions. Related Companies: BioCardia Major Shareholders Genetic Technologies Major Shareholders Moleculin Biotech Major Shareholders Novo Integrated Sciences Major Shareholders Centogene Major Shareholders MIRA Pharmaceuticals Major Shareholders Avalo Therapeutics Major Shareholders Biomerica Major Shareholders Addex Therapeutics Major Shareholders Elevai Labs Major Shareholders This page (OTCMKTS:BTCY) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
